$50 Billion And 100,000 Plaintiffs: Johnson & Johnson’s Painful Reputational Risk Lesson

 Friday, November 1, 2019

 Risk & Insurance

Health product manufacturer Johnson & Johnson has yet to evade the laundry list of class action lawsuits held against it.

Everything from mounting opioid litigation to the more recent asbestos allegations has placed this conglomerate under national public scrutiny.

Courtrooms across the country have demanded billions of dollars from J&J to date (though one judge believes he may have added three too many zeros to his verdict).

J&J has, so far, taken the approach of battling many of the more than 100,000 plaintiffs in court. It’s a decision that has some scratching their heads; after all, J&J seems to be on a legal losing streak.
LiabilityExcess & Surplus Lines